risk of pancreatitis with glp 1 Dose-dependent associated GLP-1 agonists | Journal Diabetes & Metabolic Disorders Risk of pancreatic cancer associated
Description
I called up every pharmaceutical company with a name that was familiar and said I had a patent that could be useful in developing a treatment for diabetes. But big pharmaceutical companies move slowly
Originally approved for diabetes, GLP-1 drugs are positively used in the management of weight loss, cardiovascular risk, fatty liver disease, and neurodegenerative conditions
The higher real-world figure reflects what happens when medication is combined with ongoing clinical monitoring, behavioural coaching, and dose adjustment over time
Some people find that the oral version is harder on the stomach, while others feel just fine
2024;22(10):1999-2010.e8
Incomplete submissions restart the review timeline, so ensuring all required lab results and clinical notes are included prevents delays
